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In acute stroke, OSA has been found to impair rehabilitation and increase mortality but the effect of central apnea is more unclear.
The aim of the present study was to evaluate the feasibility of using limited ambulatory recording system (sleep mattress to evaluate
nocturnal breathing and EOG-electrodes for sleep staging) in sleep disordered breathing (SDB) diagnostics in mild acute cerebral
ischemia patients and to discover the prevalence of various SDB-patterns among these patients. 42 patients with mild ischemic
stroke or transient ischemic attack were studied. OSA was found in 22 patients (52.4%). Central apnea was found in two patients
(4.8%) and sustained partial obstruction in only one patient (2.4%). Sleep staging with EOG-electrodes only yielded a similar
outcome as scoring with standard rules. OSA was found to be common even after mild stroke. Its early diagnosis and treatment
would be favourable in order to improve recovery and reduce mortality. Our results suggest that OSA can be assessed by a limited
recording setting with EOG-electrodes, sleep mattress, and pulse oximetry.
1. Introduction
Sleep disordered breathing (SDB) is common in cerebrovas-
cular disease [1]. In particular, obstructive sleep apnea (OSA)
constitutes a risk factor for cerebrovascular events, and it is
frequently seen in patients with both stroke and transient
ischemic attack (TIA) [1, 2]. OSA is known to increase stroke
mortality and it worsens the outcomes of rehabilitation [3–
5]. Continuous positive airway pressure (CPAP) treatment for
OSA in stroke patients has been found to decrease mortality,
improve functional recovery, increase subjective well-being
and mood, and inhibit recurrent strokes [6–10]. The effect of
central apneas onmortality and functional recovery in stroke
patients is less studied, but in one study central apnea did not
increase mortality after stroke as OSA did [11].
Even though routine screening of OSA in the stroke units
is becoming more common, it is not usually performed in
the stroke units in Finland. One reason for this might be that
patients with both stroke and OSA do not present the typical
clinical picture of sleep apnea; they are oftenneither obese nor
sleepy [4, 12, 13]. In addition, it might be that sleep studies are
considered cumbersome in acute hospital wards. Patients in
stroke units may have many different monitoring devices, as
well as nasal supplementary oxygen therapy, and performing
nocturnal polygraphy with additional sensors is perhaps not
favored.
Sleepmattresses provide a noninvasivemeans to diagnose
SDB. Both the SCSB (static charge sensitive bed) and the
Emfit movement sensor have been proven to be suitable
in detecting sleep apnea [14, 15]. SDB diagnostics with the
movement sensor is patient-friendly, and the manual scoring
procedure, performed in 3min epochs, is easy and rapid.
However, in limited polygraphy settings without EEG, the
apnea-hypopnea index (AHI) tends to be lower than in
full polysomnography (PSG) recordings [16]. In acute wards
patients often sleep poorly due to the nursing and treatment
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time schedules.Therefore some estimation of total sleep time
would be beneficial.
With this study we aim to discover the prevalence of
obstructive and central sleep apnea as well as prolonged
partial obstruction, among mild stroke and TIA patients
in Finland. Prolonged partial obstruction is associated with
continuous increase in respiratory resistance without apneas
or hypopneas [17–19]. It is easily detected by the SCSB and
the Emfit sensors, and its prevalence in stroke patients has
not been previously studied.
In additionwe aim to determinate whether limited polyg-
raphy consisting of movement sensor and pulse oximetry
in order to evaluate nocturnal breathing combined with
electrooculography-signal (EOG) in order to evaluate sleep
time will provide a diagnostic means of adequate quality in
detecting SDB.
2. Materials and Methods
Patients were recruited from the Stroke Unit of Tampere Uni-
versity Hospital betweenMay and October, 2010. All patients
were hospitalized due to ischemic cerebral stroke or transient
ischemic attack (TIA). The initial eligibility criteria for the
study were as follows: (a) TIA or mild ischemic stroke, the
severity defined as National Institutes of Health Stroke Scale
(NIHSS) score < 12, and (b) no previous CPAP treatment for
OSA. The researcher evaluated the NIHSS score at the ward
and the following demographic data were gathered: age, sex,
BMI, neck circumference, previous diseases, smoking, use of
alcohol, subjective sleep problems (snoring and apnea) in the
weeks before the stroke, and increased daytime sleepiness.
For sleepiness the following question was presented: “were
you sleepier than usual a couple of days before the stroke?”
The study was approved by the Ethical Committee of the
Pirkanmaa Hospital District and all the subjects gave their
written informed consent. If OSA was found, the subject was
referred to the Sleep Center to evaluate the need for CPAP
treatment. The pulmonologist then began CPAP treatment
according to the standards of our hospital.
2.1. Recording Montage. The polygraphic recordings were
performed during the first night in the hospital, whenever
possible. The recordings were made in the stroke unit or at
the neurologicward.The limited polygraphy setting consisted
of two EOG channels (EOG P8-A2, EOG P18-A2), electro-
cardiography, pulse oximetry, and the Emfit sensor (32 cm ×
62 × 0.4 cm, placed under the thoracic area of the patient).
In 14 randomly selected patients nocturnal sleep quality and
breathing were assessed with full polysomnography, which
consisted of the same sensors as the limited polygraphy and
additionally six EEG channels (F3-A2, C3-A2, O1-A2, F4-
A1, C4-A1, and O2-A1), submental and anterior tibialis mus-
cle electromyography, thoracic and abdominal respiratory
movements by inductive belts, and position. Airflow was
measured with a thermistor and also with a nasal pressure
transducer if the patient did not have nasal supplementary
oxygen therapy. A sampling rate of 2Hz was used for pulse
oximetry, 10Hz for respiratory movements, 500Hz for ECG,
and 200Hz for the Emfit sensor and the other signals.
2.2. Visual Analysis. The full polysomnographies (PSG) were
classified into the sleep stages according to the standard
criteria. The apnea-hypopnea index (AHI) was calculated as
the number of obstructive apneas and hypopneas (hypopnea
rule 4b in [20]) per hour of sleep. Arousals were scored
according to the criteria of the ASDA [21]. To evaluate the
feasibility of the intended EOG sleep staging we classified the
full polysomnographies into the sleep stages by means of the
EOG-signals, without EEG or EMG, too [22].The amounts of
sleep and sleep stages comprised by the two differentmethods
were then compared.
The limited polygraphs (POL) were classified into the
sleep stages utilizing only the EOG signals. The respiratory
analysis of the limited polygraphswas performed by the Emfit
signal. Emfit signal was scored into one of ten categories in
3min epochs as in our previous work [15, 19]. The mattress
signal categories used were as follows: normal breathing
(NB), periodic breathing type 1 (P1), obstructive periodic
breathing types 1–3 (OP1–3), central periodic breathing
(CP), prolonged partial obstruction (increased respiratory
resistance, IRR), large movement artifacts lasting >40 s (M),
epochs with at least four short periodic movements in all
channels without respiratory variation (periodic movements,
PM), and wake epochs (W) with EEG-defined wakefulness
for more than 50% of time.The wakefulness epochs were not
included in the further analyses.The respiratory results of the
mattress breathing analyses are presented in percentages of
total sleep time derived from the EOG scoring.
The EEG scorings were performed by two clinical neu-
rophysiologists. The median scoring agreement was 84.1%
(76.4–86.7%) with the median Kappa value being 0.71 (range
0.67–0.81). The consensus scorings were used in the final
analyses. The further analyses of the recordings were per-
formed from the first sleep onset after 8 PM to the final
awakening in the morning. Obstructive AHI ≥ 15/h was
selected to designate marked obstructive sleep apnea. Based
on our previous study an obstructiveAHI of 15/h corresponds
well with obstructive periodic breathing time (%OP1 +%OP2
+ %OP3) of 21% in Emfit scoring [15]. Thus the cut-off
values of obstructive AHI ≥ 15/h and obstructive periodic
time percentage of ≥21 were selected to define marked OSA
and such patients were classified into the OSA group. The
same cut-off values were used to define the central apnea
group (central AI ≥ 15/h or central periodic breathing of
≥21%). The third group was comprised of the patients having
a prolonged partial obstruction (IRR) percentage ≥21%, with
both obstructive AHI and central AI less than 15/h (IRR
group). The remaining patients composed the non-SDB
group.
2.3. Statistics. In the statistical comparisons, nonparamet-
ric tests were used, since all the variables were not nor-
mally distributed. The comparison between the two sleep
staging procedures (standard scoring versus EOG scoring)
was performed by Spearman’s correlation coefficient and
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Cohen’s Kappa-analysis [23]. Pair-wised comparisons of
related parameters were conducted by using the Wilcoxon
test. The patient groups were compared with the Mann-
Whitney test. The demographic data (sex, age, BMI, previous
depression, previous stroke, previous heart failure, hyperten-
sion, hypercholesterolemia, diabetes mellitus, hypothyreosis,
asthma, COPD, previous other lung diseases, use of tobacco,
use of alcohol, NIHSS-score, snoring, witnessed apneas, and
increased sleepiness) were evaluated with the binary logistic
regression analysis. In statistical analyses𝑃 values< 0.05 were
considered statistically significant.
3. Results
Altogether 46 patients volunteered for the study. Fourteen
patients were recruited for full polysomnography but only
twelve recordings were completed (86%). One patient wanted
the sensors to be detached soon after starting the recording,
and one recording terminated unexpectedly at 11 p.m.Thirty-
two patients were examined by using the limited polygraphy.
Two of these recordings (6%) were excluded from the
analyses; one patient wanted the recording to be stopped just
before falling asleep and in one recording both the Emfit
and pulse oximetry signals were missed. In total, 42 patients
were accepted into the analyses.The polysomnography group
(PSG) consisted of one female patient and eleven male
patients, whereas in the limited polygraphy (POL) group, 17
patients were female and 13 were male. The analysis start
times varied between 20 : 06 and 02 : 45, withmedian of 21 : 19.
In order to ensure the feasibility of the sleep stage scoring
based on the EOG electrodes, we compared the sleep stage
results derived by using the two scoring methods in the PSG
group. The sleep staging agreement between the standard
scoring method and the EOG scoring was 82.2% (median,
range 56.3–88.2%). The median Kappa value was 0.72 (0.41–
0.80), indicating substantial agreement [23]. The total sleep
time (TST) estimated by the EOG scoring correlated well
with the TST measured by standard scoring (Spearman’s
correlation coefficient 0.964). The sleep stage parameters are
presented in Table 1. The total amount of sleep was higher
by the EOG scoring than by the standard scoring (353.5min
versus 321min, resp., Table 1), but the difference remained
at the edge of statistical significance. The percentages in the
amounts of various sleep stages between the two scoring
procedures did not yield to statistically significant differences.
Figure 1 depictures the hypnograms with the lowest sleep
staging agreement between the standard scoring and the
EOG scoring (56.3%, Kappa 0.41 = moderate concordance).
The sleep stage parameters of all 42 patients are presented
in Table 2.Themedian sleep efficiency, as well as the amounts
of deep sleep and REM-sleep, was in general quite low even
if most of the subjects slept subjectively well or fairly well
during the study night (45% and 36%, resp.). Seventeen
percent of the patients slept poorly and one patient (2%) felt
that he had not slept at all (his total sleep time was 3 h).
Eight out of the twelve subjects in the PSG group had
AHI ≥ 15/h (one female, 7 men). In the POL group 14 patients
had obstructive periodic breathing ≥21% of TST (8 female, 6
male). The respiratory parameters of the PSG group and the
POL group are presented in Table 3. We also calculated the
AHI for sleep period time in the PSG group (sleep period
time, time from sleep onset to the final awakening with
wakefulness time inside the sleep period included). The AHI
for the sleep period timewas significantly lower than the AHI
derived from TST (13.3/h, range 0.5–48.5, versus 18.1/h range
1.2–67.9,𝑃 value 0.002).While eight patients out of twelve had
AHI > 15/h when TST was applied, only three patients had
AHI > 15/h if sleep period time was used.
Altogether 17 subjects (40.5%, 9 males, 8 females) did not
have sleep disordered breathing (non-SDB group, Table 4)
when the PSG and the POL groups were pooled. The
remaining patients had either obstructive or central breath-
ing disorder; no one had both abnormal obstructive and
abnormal central indices. OSA was found in 22 patients
(52.4%, OSA group). Nine of these patients were female
(41%). Central apnea was found in two male patients (4.8%,
central group). IRR was found only in one female patient
(2.4%, IRR group). In general the study subjects had very
mild stroke as assessed by the NIHSS and they were not
very overweight. Statistical comparisons were made between
the non-SDB and the OSA groups only as the central group
and the IRR group remained so small. There were only few
statistically significant differences between the non-SDB and
OSA groups; the subjects in the non-SDB group had more
slow wave sleep (N3), and their oxygen desaturation indices
(ODI4) were lower.
More demographic parameters are presented in Table 5.
Hypertension, snoring, and increased sleepiness were fre-
quent in all subject groups. The demographic variables
were evaluated with the binary logistic regression analysis.
Only increased sleepiness was identified as an independent
predictor of the stroke in the non-SDB group with OR = 5.33
(CI 1.32–21.53).
4. Discussion
In the present study the prevalence of SDB amongmild stroke
and TIA patients was 59.5%. Our result for the prevalence
of OSA (52.3%) in patients with TIA or mild stroke is in
concordance with those of a previous study [24]. Only two
subjects were found to have marked central apnea (4.8%),
but this corresponds with the findings in a previous meta-
analysis [25]. The prevalence of IRR in the present study was
lower (2.4%) than the prevalence among our sleep laboratory
patients (10.2%) [15].The cut-off limit we previously used was
lower (≥15%) but even if the value had been used, the number
of IRR-patients in the present study would not have changed.
OSA increases sympathetic tone [26], inducing hyper-
tension which may be a predisposing factor for stroke.
However, there aremany physiologicmechanisms behind the
increase in blood pressure in OSA. For example, the hypoxia
associatedwith periodic apnea augments sympathetic activity
and blood pressure with an additional increase caused by
repetitive arousals, restoring the upper airway patency [27–
29]. IRR represents a different SDB entity since the periods
with partial obstruction may last several minutes without
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Table 1: Sleep stage parameters of the PSG group with the two different scoring systems.
Standard scoring EOG scoring
𝑃 value
Median (min–max) Median (min–max)
TST (min) 321 (48.5–506.5) 353.5 (49.5–498.5) 0.051
SEI (%) 72.2 (42–90.9) 69.1 (42.9–89.4) 0.48
% N1 12.8 (6.5–41.2) 15.4 (6.8–48.5) 0.068
% N2 69.5 (36.1–83.2) 66.2 (37.4–82.4) 0.33
% N3 7.0 (0–23.6) 5.9 (0–17.7) 0.17
% REM 11.2 (0–22.3) 12.9 (0–25.4) 0.61
Standard scoring: sleep stage scoring according to the standard rules; EOG scoring: sleep stage scoring based on the two EOG (electrooculography) channels
only; TST: total sleep time; SEI: sleep efficiency index referred to analysis time; % N1–N3: percentage of N1–N3 sleep referred to TST; % REM: percentage of
REM sleep referred to TST. Statistical comparisons with the Wilcoxon test.
Wake
REM
N1
N2
N3
(a)
Wake
REM
N1
N2
N3
22:00 23:00 0:00 1:00 2:00 3:00 4:00 5:00
(b)
Figure 1: Example of the hypnograms of the same patient derived by the two different sleep staging procedures. The upper hypnogram
represents standard sleep staging and the lower hypnogram represents EOG scoring. The hypnograms resemble each other but there are
differences in both sleep efficiency (69% by standard sleep staging, 59% by EOG-scoring) and the arrangement of the sleep stages.The patient
had moderate OSA (AHI 18.8/h).
Table 2: The sleep quality parameters of the 42 patients.
Median Min Max
TST (min) 368.5 48.5 510.5
SEI (%) 70.8 27.5 97.6
% N1 8.8 1.8 41.2
% N2 46.9 3.3 83.2
% N3 6.5 0 26.2
% REM 7.1 0 31.2
TST: total sleep time; SEI: Sleep Efficiency Index referred to analysis time; %
N1–N3: percentage of N1–N3 sleep referred to TST; % REM: percentage of
REM sleep referred to TST.
arousals. In that way the increase in sympathetic activity
induced by arousals does not emerge. In addition the pre-
vailing airflow against resistance during IRR is capable of
activating the pulmonary stretch receptors, which leads to
the inhibition of sympathetic activation [30]. Thus, it might
be that IRR does not constitute a marked risk factor for
hypertension. Indeed, it has been presented that women
with IRR have less hypertension than women in the general
population [31]. It is possible that the risk of cardiovascular
events of IRR patients might be reduced as compared to OSA
patients. Thus the present study increases our knowledge of
IRR, but its profound significance still remains somewhat
obscure and requires further evaluation.
In the present study, the neck circumference measure-
ment did not differ between the OSA group and the non-
SDB group. This might be due to the fact that the BMI of
our patients was not high in general. Similar results have
been found earlier [13, 24]. In addition, our OSA patients
did not present increased daytime sleepiness before stroke,
unlike those who did not have OSA.The absence of excessive
daytime sleepiness has been noted before [13]. It may be that
patients with OSA do not necessarily recognize increased
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Table 3: The respiratory parameters of the PSG group and the POL group.
PSG group POL group
Median Min Max Median Min Max
AHI obstructive (𝑛/h) 18.1 1.2 67.9
AHI central (𝑛/h) 0 0 1.2
ODI4 4.5 0 32.5 6.0 0 64.8
% OP1–OP3 27.2 2.6 69.3 14.1 0 45.8
% CP 0 0 4.7 0 0 51.6
% IRR 0.8 0 9.6 0.5 0 25.4
SaO2min (%) 87.5 79.0 93.0 85.0 75.0 91.0
SaO2mean (%) 93.7 90.7 96.5 93.2 89.5 97.1
Pulse (bpm) 55 46 73 58 46 86
AHI obstructive: number of obstructive apneas and hypopneas per hour of sleep; AHI central: number of central apneas per hour of sleep; ODI4: number of
desaturations per hour of sleep; %OP1–OP3: percentage of time with obstructive periodic breathing as detected by Emfit sensor; % CP: percentage of time with
central periodic breathing as detected by Emfit sensor; % IRR: percentage of time with prolonged partial obstruction as detected by Emfit sensor; SaO2min:
minimum oxygen saturation percentage; SaO2mean: average oxygen saturation percentage; Pulse: mean pulse per minute.
Table 4: Some demographic and sleep parameters of the different subject groups.
Non-SDB, 𝑛 = 17 OSA, 𝑛 = 22 Central, 𝑛 = 2 IRR, 𝑛 = 1 Non-SDB versus OSA
Median (min–max) Median (min–max) Median (min–max) Value 𝑃 value
BMI 26.0 (19.9–32.7) 26.6 (21.9–37.4) 25.3 (25.2–25.3) 27.5 0.705
AGE 62 (45–79) 69 (37–82) 77 (75–78) 68 0.131
TST 426 (49–511) 321 (105–490) 300 (282–318) 416 0.116
SEI 72.8 (42.0–97.6) 70.3 (27.5–95.7) 65.2 (61.3–69.1) 67.2 0.236
% N1 8.9 (2.6–41.2) 9.0 (1.8–23.0) 12.5 (11.9–13.1) 8.2 0.962
% N2 45.9 (33.1–73.9) 57.8 (3.3–83.2) 44.7 (42.7–46.7) 53.6 0.168
% N3 12.4 (3.3–26.2) 4.3 (0–23.6) 1.5 (1.1–1.8) 2.4 0.005
% REM 6.9 (0–22.3) 10.8 (1.0–31.2) 6.9 (5.2–8.5) 3.1 0.539
ODI4 1.8 (0–8.2) 16.4 (0–64.8) 9.7 (4.2–15.1) 0.7 0.000
SaO2min (%) 87 (80–91) 85 (75–93) 87 (84–89) 85 0.053
SaO2mean (%) 93.6 (90.7–97.1) 93.3 (89.5–96.8) 94.5 (93.3–95.7) 91.7 0.975
Pulse (bpm) 61 (50–86) 58 (46–78) 51 (50–52) 51 0.133
NIHSS 2 (0–6) 1 (0–4) 3 (2–4) 1 0.138
Neck (cm) 40 (34–44) 41 (38–53) 41 (40–42) 39 0.231
NIHSS: National Institutes of Health Stroke Scale; Neck: neck circumference in centimeters.
The rest of the abbreviations are as in Tables 1 and 3. Statistical comparisons between the Non-SDB group and the OSA group with the Mann-Whitney test.
sleepiness due to the chronic sleepiness induced by OSA.The
problem with our study is that sleepiness was not evaluated
structurally, so it is not possible to draw strong conclusions.
In a previous meta-analysis the prevalence of female
patients with OSA and stroke was found to be 35.4% [25].
In our study, the percentage of females with OSA was 41%.
In that way, the portion of female patients is clearly larger
than the prevalence of OSA in females in general [32]. It
has been shown that females may present atypical SDB-
related symptoms, for example, insomnia and depression
[33], and the remarkable portion of female patients among the
OSA + stroke patients may, in part, account for the atypical
subjective complaints among these patients. It is possible that
routine anamnesis as it conventionally relates to OSA does
not necessarily reveal SDB in stroke patients, which stresses
the need for OSA screening in stroke units.
Patients tend to sleep poorly in the hospital, and also
the objective sleep quality of our patients was poor, as
assessed by sleep efficiency. In most of the sleep record-
ings we utilized only the two EOG channels in the sleep
stage scoring (EOG scoring) to achieve an estimate of TST.
As a result, the total sleep time obtained by the EOG
scoring correlated well with the standard scoring results.
According to previous studies sleep staging by EOG sig-
nal seems relatively reliable and promising [22, 34] and
because the EOG signals can be recorded by disposable
electrodes, the attachment of the electrodes is easy. Our
results suggest that sleep staging with EOG results in
more valid diagnostic SDB outcome than conventional
respiratory polygraphy without sleep staging even if the
EOG scoring procedure may overestimate the amount of
sleep.
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Table 5: Demographic parameters of the 42 patients.
Non-SDB OSA Central IRR
Depression (%) 5.9 4.5 0 0
Previous stroke (%) 5.9 13.6 0 0
Heart failure (%) 23.5 27.3 0 0
Hypertension (%) 47.1 63.6 50 100
Hypercholesterolemia (%) 11.8 13.6 0 0
Diabetes mellitus (%) 5.9 4.5 0 0
Hypothyreosis (%) 5.9 4.5 0 100
Asthma (%) 5.9 0 0 0
COPD (%) 17.6 4.5 0 0
Tobacco use (%) 47 18.1 50 0
Alcohol use (%) 29.4 22.7 0 0
Snoring (%) 52.9 54.5 50 100
Witnessed apneas (%) 5.9 22.7 50 0
Increased sleepiness 76.5 40.9 0 100
COPD: chronic obstructive pulmonal disease.
Our other aim was to evaluate the feasibility of limited
polygraphy with a sleep mattress in screening SDB. The
clinical evaluation of mattress signal is easy and fast and,
depending on the recording device used, adding different
additional signals is often simple. In the present study, the
percentage of successful recordings was higher in the POL
group than in the PSG group, which supports the use of the
limited recording montage in acute wards. If the number
of recorded parameters is kept low, the system does not
disturb the patient, enabling recordings for several nights
when needed.
5. Conclusion
In the present study we concentrated on mild stroke and
TIA patients only, and the recordings were made soon after
the stroke. In general, patients with TIA and mild stroke
recover well, but, according to the current knowledge, they
have an increased risk of stroke recurrence [35]. As recurrent
stroke might be inhibited by the proper treatment of SDB
[6], screening for SDB should be favoured in the stroke units.
Our results suggest that limited and less disturbing recording
setting is sufficient to reveal OSA in stroke units.
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